Li Cheng

3.5k total citations
146 papers, 2.3k citations indexed

About

Li Cheng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Li Cheng has authored 146 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 45 papers in Cancer Research and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Li Cheng's work include MicroRNA in disease regulation (29 papers), Cancer-related molecular mechanisms research (16 papers) and Circular RNAs in diseases (13 papers). Li Cheng is often cited by papers focused on MicroRNA in disease regulation (29 papers), Cancer-related molecular mechanisms research (16 papers) and Circular RNAs in diseases (13 papers). Li Cheng collaborates with scholars based in China, United States and Germany. Li Cheng's co-authors include Chongchong Wang, Juehua Jing, Shuisheng Yu, Hengsheng Chen, Jun Hu, Siqi Hong, Xiqun Jiang, Min Kong, Ziyu Li and Zhuo Dong and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Li Cheng

132 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Cheng China 29 1.2k 707 282 240 197 146 2.3k
Jie Bai China 27 1.9k 1.5× 443 0.6× 276 1.0× 171 0.7× 125 0.6× 118 2.9k
Xiaohui Wang China 29 1.5k 1.2× 956 1.4× 253 0.9× 448 1.9× 211 1.1× 133 3.0k
Xueyuan Liu China 30 1.5k 1.2× 511 0.7× 249 0.9× 262 1.1× 125 0.6× 144 3.1k
Shuang Wang China 29 1.5k 1.2× 1.0k 1.4× 220 0.8× 147 0.6× 130 0.7× 108 3.0k
Laura C. Greaves United Kingdom 32 2.3k 1.8× 448 0.6× 228 0.8× 373 1.6× 279 1.4× 54 3.5k
Nicole Wagner France 34 2.7k 2.2× 541 0.8× 374 1.3× 221 0.9× 261 1.3× 72 3.7k
Qian Sun China 28 1.1k 0.9× 535 0.8× 346 1.2× 313 1.3× 119 0.6× 98 2.8k
Xinxin Yang China 23 959 0.8× 351 0.5× 254 0.9× 187 0.8× 144 0.7× 163 2.3k
Natalya D. Bodyak United States 25 1.9k 1.5× 428 0.6× 158 0.6× 219 0.9× 237 1.2× 47 3.1k
Jie Yin China 31 1.6k 1.3× 829 1.2× 365 1.3× 478 2.0× 421 2.1× 161 3.1k

Countries citing papers authored by Li Cheng

Since Specialization
Citations

This map shows the geographic impact of Li Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Cheng more than expected).

Fields of papers citing papers by Li Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Cheng. The network helps show where Li Cheng may publish in the future.

Co-authorship network of co-authors of Li Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Li Cheng. A scholar is included among the top collaborators of Li Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Cheng. Li Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Haiyang, et al.. (2025). Mapping Knowledge Structure and Themes Trends of Ewing Sarcoma: A Text-Mining Study. Annals of Surgical Oncology. 32(5). 3724–3740. 1 indexed citations
2.
Cheng, Li, et al.. (2024). Discovery of novel BCL6-Targeting PROTACs with effective antitumor activities against DLBCL in vitro and in vivo. European Journal of Medicinal Chemistry. 277. 116789–116789. 8 indexed citations
3.
Zhou, Liang, Li Cheng, Youyou Li, et al.. (2024). Endocrine cancer trends 1990–2021: global disparities and health inequalities. Endocrine Related Cancer. 31(11). 6 indexed citations
4.
Chen, Hengsheng, et al.. (2024). Protective effects of docosahexaenoic acid supplementation on cognitive dysfunction and hippocampal synaptic plasticity impairment induced by early postnatal PM2.5 exposure in young rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(9). 6563–6575. 1 indexed citations
5.
Cheng, Li, et al.. (2024). Histopathological Characteristics and Inflammatory Cell Infiltration in Sinonasal Inverted Papilloma. American Journal of Rhinology and Allergy. 39(1). 21–31. 2 indexed citations
6.
Luo, Yang, Fei Yao, Zhenyu Zhu, et al.. (2023). Tocilizumab promotes repair of spinal cord injury by facilitating the restoration of tight junctions between vascular endothelial cells. Fluids and Barriers of the CNS. 20(1). 1–1. 9 indexed citations
7.
Yang, Xiaoyue, et al.. (2023). Identification of novel proteins for sleep apnea by integrating genome-wide association data and human brain proteomes. Sleep Medicine. 114. 92–99. 12 indexed citations
8.
Li, Yiteng, Yi‐Hao Chen, Xuyang Hu, et al.. (2023). Fingolimod (FTY720) Hinders Interferon-γ-Mediated Fibrotic Scar Formation and Facilitates Neurological Recovery After Spinal Cord Injury. Journal of Neurotrauma. 40(23-24). 2580–2595. 5 indexed citations
9.
10.
Li, Wenjing, Jingjing Xu, Li Cheng, et al.. (2021). RelB promotes the migration and invasion of prostate cancer DU145 cells via exosomal ICAM1 in vitro. Cellular Signalling. 91. 110221–110221. 11 indexed citations
11.
Li, Jia, Huiyu Wang, Zhaoyan Li, et al.. (2020). A 5‐Gene Signature Is Closely Related to Tumor Immune Microenvironment and Predicts the Prognosis of Patients with Non‐Small Cell Lung Cancer. BioMed Research International. 2020(1). 2147397–2147397. 13 indexed citations
12.
Adamia, Sophia, Ivane Abiatari, Samirkumar B. Amin, et al.. (2019). The effects of MicroRNA deregulation on pre-RNA processing network in multiple myeloma. Leukemia. 34(1). 167–179. 9 indexed citations
13.
Cheng, Li, et al.. (2019). Vestibular rehabilitation improves the balance of persons with Parkinson′s disease. Zhonghua wuli yixue zazhi. 41(4). 287–290.
14.
Zhang, Hao, Qianyun He, Dake Tong, et al.. (2018). miR-422a inhibits osteosarcoma proliferation by targeting BCL2L2 and KRAS. Bioscience Reports. 38(2). 26 indexed citations
15.
Wang, Zicheng, Haili Li, Li Cheng, et al.. (2018). Inflammatory Stimuli Significantly Change the miRNA Profile of Human Adipose-Derived Stem Cells. Stem Cells International. 2018. 1–9. 3 indexed citations
16.
Huang, Hsin‐Yi, Wenjing Zhang, Yijun Gao, et al.. (2017). YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregulation of the DNp63–GPX2 Axis and ROS Accumulation. Cancer Research. 77(21). 5769–5781. 68 indexed citations
17.
Guan, Min, et al.. (2017). Effect of motor relearning programme on motor function recovery of acute stroke patients with hemiplegia. SHILAP Revista de lepidopterología. 4 indexed citations
18.
Cheng, Li, Yahui Zhu, Han Han, et al.. (2017). MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice. Cell Death and Disease. 8(7). e2916–e2916. 52 indexed citations
19.
Zhang, Wenqian, Yuyuan Dai, Ping‐Chih Hsu, et al.. (2017). Targeting YAP in malignant pleural mesothelioma. Journal of Cellular and Molecular Medicine. 21(11). 2663–2676. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026